Indoco Remedies Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BROMFENAC SODIUM, with a corresponding US DMF Number 25245.
Remarkably, this DMF maintains an Active status since its submission on August 18, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 09, 2013, and payment made on August 28, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II